E11
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient was taking treatment for diabetes type 2 from the out-patient department of the Bangladesh Institute of Health Sciences (BIHS) hospital, Dhaka 2. Patient has a personalized mobile phone 3. Voluntary participation
Exclusion criteria
Exclusion criteria: 1. Patient was taking treatment for other than diabetes type 2 from the out-patient department of the Bangladesh Institute of Health Sciences (BIHS) hospital, Dhaka 2. Patient has no personalized mobile phone 3. Not willing to participation
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Measured after one year of implementation of the mobile health project. Biomedical outcomes: the patient was considered at a controlled blood glucose level or adherent if fasting blood glucose level was <7.0 mmol/L, and blood glucose level two hours after breakfast was <11.1 mmol/L (according to WHO reference value). | — |
Primary
| Measure | Time frame |
|---|---|
| Increase patient adherence to the treatment recommendation (for drug, diet, physical exercise, use of smoke/smokeless tobacco, betel nuts). It has been measured after one year implementation of the mobile health project. Adherence was measured according to the following criteria: 1) Adherence to drug intake: the patient was considered adherent if s/he had taken the drug(s) according to the physician’s advice for dose, frequency, route of administration and duration of the treatment and without having missed any intake; 2) adherence to lifestyle behavioral changes: a) Diet: the patient was considered adherent if the calorie intake (carbohydrate CHO, protein, fat, and total Kilocalorie) was within a 10% margin (positive or negative) of the recommended value (according to patient book). Vegetable and fruit intake practice was analyzed according to recommendation, b) Physical exercise: the patient was considered adherent if s/he was walking at least 30-minutes per day for at least five days or 150 minutes in a week (according to WHO recommendations), c) Cessation of smoke or smokeless tobacco and betel nut: the patient was considered adherent if they stopped using smoke or smokeless tobacco and betel nut (according to physician advice). | — |
Countries
Bangladesh
Contacts
Faculty of Health/Department of Human Medicine, University Witten/Herdecke, Germany. Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg, Germany.